Scientists successfully grew stem cells aboard International Space Station in a new study. Scientists are cultivating stem cells in space to uncover new techniques to manufacture large quantities of stem cells to cure ailments. Cedars-Sinai Medical Center in Los Angeles is behind the operation that sent stem cells to the International Space Station (ISS) over the weekend. The effort is the nineth of its kind to send stem cells to space from the U.S., China, and Italy.                                                                                                                                                                                                                                                                                                                                                                                                                               The initiatives are trying to overcome the challenges of growing vast quantities of stem cells under Earth's gravity by conducting them beyond the planet's atmosphere. In Zero-G, there's no force on the cells, so they may develop differently. The cells employed in the Cedar-Sinai experiment are pluripotent stem cells (iPSCs). These compounds are used for treatments ranging from skin to blood cells.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                ISS National Laboratory is said that human iPSCs are useful for designing and testing personalized medicines. Microgravity may overcome several obstacles in the process by which stem cells proliferate and become other types of cells, which might progress the manufacture of iPSCs for the treatment of many diseases on Earth. Cedar-Sinai leaders said they are delighted to pursue the study with the objective of enhancing theraputic therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                The promise of regenerative medicine is out of this world. The endeavor entails producing a similar group of stem cells on Earth for comparison. The stem cells aboard the ISS will be returning in a few weeks on a Space X spaceship and examined.                                               -FREEDOMBEACON.COM